Martin Sjöström
11 – 20 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reply to V. Nardone et al
- Contribution to journal › Debate/Note/Editorial
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
- Contribution to journal › Article
-
Mark
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
- Contribution to journal › Article
- 2022
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
- Contribution to journal › Article
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
- Contribution to journal › Article
-
Mark
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
- Contribution to journal › Article
- 2021
-
Mark
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance
- Contribution to journal › Article
- 2020
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- Contribution to journal › Article
-
Mark
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery : a long-term follow-up of the SweBCG91-RT randomised trial
- Contribution to journal › Article
